Kunitada Shimotohno

Kunitada Shimotohno

Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine

Affiliated withNational Center for Global Health and Medicine

Research Area

Biography

Kunitada Shimotohno has not added Biography.
If you are Kunitada Shimotohno and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Publication title

Cited by 2

2017

Other Publications

Article
Year
RelA suppresses the Wnt/beta-catenin pathway without exerting trans-acting transcriptional ability.

International journal of molecular medicine| PubMed ID: 11956654

2002
Subgenomic replicon derived from a cell line infected with the hepatitis C virus.

Biochemical and biophysical research communications| PubMed ID: 12051758

2002
Hepatitis C virus and its roles in cell proliferation.

Journal of gastroenterology| PubMed ID: 12109666

2002
2002
2002
2002
2003
2003
2003
Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro.

Biochemical and biophysical research communications| PubMed ID: 12810084

2003
2003
2003
2003
2003
2003
2003
2003
2004
2004
2004
2004
2004
Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype.

Biochemical and biophysical research communications| PubMed ID: 15351737

2004
[Gene organization of hepatitis C virus and its sequence diversity].

Nihon rinsho. Japanese journal of clinical medicine| PubMed ID: 15359758

2004
[Processing of HCV precursor polyprotein].

Nihon rinsho. Japanese journal of clinical medicine| PubMed ID: 15359763

2004
2004
2005
2004
2005
2005
2005
2005
2005
2005
Role of cyclophilin B in activation of interferon regulatory factor-3.

The Journal of biological chemistry| PubMed ID: 15764595

2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2006
2006
Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811.

Biochemical and biophysical research communications| PubMed ID: 16564500

2006
2006
2006
2006
2006
Inhibition of hcv replication in HCV replicon by shRNAs.

Nucleosides, nucleotides & nucleic acids| PubMed ID: 16898418

2006
High expression of APOBEC3G in patients infected with hepatitis C virus.

Journal of molecular histology| PubMed ID: 17036163

2006
Helper virus-independent trans-replication of hepatitis C virus-derived minigenome.

Biochemical and biophysical research communications| PubMed ID: 17112469

2007
2007
RNAi expression mediated inhibition of HCV replication.

Nucleic acids symposium series (2004)| PubMed ID: 17150601

2004
Suppression of HCV RNA replication by baculovirus-mediated shRNA expression.

Nucleic acids symposium series (2004)| PubMed ID: 17150772

2005
2007
2007
2007
2007
Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 17460044

2007
2007
2007
UbcH8 regulates ubiquitin and ISG15 conjugation to RIG-I.

Molecular immunology| PubMed ID: 17719635

2008
2007
2007
2007
2007
2007
2008
2008
[Strategy of HCV proliferation].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme| PubMed ID: 18409561

2008
2008
2008
2008
3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.

Biochemical and biophysical research communications| PubMed ID: 19103167

2009
2008
2009
2009
2009
2009
2009
Hepatitis C virus utilizes lipid droplet for production of infectious virus.

Proceedings of the Japan Academy. Series B, Physical and biological sciences| PubMed ID: 19644222

2009
2009
Synthesis and anti-HCV activity of 2',5'-deoxy-5'-phenacyladenosine analogs.

Nucleic acids symposium series (2004)| PubMed ID: 19749281

2009
2009
2010
2010
Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 20724660

2010
2010
2010
2010
2010
2010
2011
2011
2011
2011
2011
2007
2012
In vitro models for analysis of the hepatitis C virus life cycle.

Microbiology and immunology| PubMed ID: 22145950

2012
2012
2011
2012
2012
PML tumor suppressor protein is required for HCV production.

Biochemical and biophysical research communications| PubMed ID: 23219818

2013
2013
2013
2014
Interferon-mediated ISG15 conjugation restricts dengue virus 2 replication.

Biochemical and biophysical research communications| PubMed ID: 24769207

2014
2014
2014
Hepatitis C virus NS5A protein enhances gluconeogenesis through upregulation of Akt-/JNK-PEPCK signalling pathways.

Liver international : official journal of the International Association for the Study of the Liver| PubMed ID: 25360475

2014
Murine Herc6 Plays a Critical Role in Protein ISGylation In Vivo and Has an ISGylation-Independent Function in Seminal Vesicles.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research| PubMed ID: 25406959

2015
2015
2015
2015
Hepatitis C virus utilizes VLDLR as a novel entry pathway.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 26699506

2016
2016
Long noncoding RNA #32 contributes to antiviral responses by controlling interferon-stimulated gene expression.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 27582466

2016